← Back to Clinical Trials
Recruiting Phase 1 NCT03721822

Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation

Trial Parameters

Condition Smoking, Cigarette
Sponsor University of Pennsylvania
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2018-10-23
Completion 2026-10-23
Interventions
[18F]NOS

Brief Summary

The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.

Eligibility Criteria

Inclusion Criteria: 1. Participants will be 18-45 years of age 2. Subject must meet one of the following criteria: NIC vapers: current e-cigarette use of nicotine at least 5 days per week for the past year, no current combustible cigarette use, cannabis vaping, or cannabis smoking during the 30 days prior to study enrollment CAN vapers: current e-cigarette use of cannabis at least 5 days per week for the past year, no current combustible cigarette use, cannabis smoking, or nicotine vaping during the 30 days prior to study enrollment Cigarette smokers: current cigarette smoking of at least 5 cigarettes per day, 4 days per week for the past year with no e-cigarette use (cannabis or nicotine) during the 30 days prior to study enrollment Dual combustible and e-cigarette users: current e-cigarette use of cannabis and/or nicotine at least 5 days per week for the past year with cigarette or cannabis smoking during the 30 day prior to study enrollment Non-Smokers: reported non-smoking history

Related Trials